Disclosures
| Abstract # | Last Name | First Name | Disclosures |
|---|---|---|---|
| 250 | Abbott | Geoffrey | LASE Innovation: Employment (full- or part-time) |
| 79 | Abdul Sater | Ali | Allysta Pharmaceuticals: Research Grants, Salary Support, in-kind support |
| 146 | Adams | Daniel | Creatv Microtech, Inc.: Employment (full- or part-time); Creatv Microtech, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 256 | Adusumilli | Prasad | ATARA Biotherapeutics: Research funding and Scientific Advisory Board Member and Consultant; ATARA Biotherapeutics: intellectual property on mesothelin-targeted CAR and other T-cell therapies; Bayer: Scientific Advisory Board Member and Consultant |
| 250 | Akyildiz | Kubra | IVIM Technology: Employment (full- or part-time) |
| 243 | Al-Mawsawi | Laith | Equillium Inc.: Employment (full- or part-time) |
| 61 | Alam | Zahidul | Unanswered |
| 165 | Albanese | Steven | Schrodinger, Inc.: Employment (full- or part-time) |
| 251 | Alem | Aude | JPT Peptide Technologies: Employment (full- or part-time) |
| 151 | Allen | Christopher | Walking Fish Therapeutics: Positions of influence such as officer, board member, trustee, spokesperson |
| 246 | Alvarado | Diego | Celldex Therapeutics: Employment (full- or part-time) |
| 65 | Alves Da Costa | Thiago | Thermo Fisher Scientific: Employment (full- or part-time) |
| 250 | Amador | Ivette | Cytek Biosciences, Inc.: Employment (full- or part-time) |
| 243 | Ampudia | Jeanette | Equillium Inc.: Employment (full- or part-time) |
| 229 | Anderson | Keon | Cytek Biosciences: Employment (full- or part-time) |
| 159 | Anderson | Stephen | Macrotope, Inc.: Ownership or partnership; Macrotope, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Macrotope, Inc.: Positions of influence such as officer, board member, trustee, spokesperson |
| 233 | Anderson | Evan | Pfizer: Consulting fees or other remuneration; Sanofi Pasteur: Consulting fees or other remuneration; GSK: Consulting fees or other remuneration; Janssen: Consulting fees or other remuneration; Moderna: Consulting fees or other remuneration; Medscape: Con |
| 85 | Anderson | Jordan | Seismic: Employment (full- or part-time) |
| 252 | Aoki | Hiroyasu | ImmunoGeneTeqs, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 79 | Apostolou | Athanasia | Emulate: Employment (full- or part-time) |
| 250 | Aragon | Virginia | Thermo Fisher Scientific: Employment (full- or part-time) |
| 155 | Arepally | Gowthami | Annexon Biosciences: Research Grants, Salary Support, in-kind support |
| 207 | Arora | Hitesh | STEMCELL Technologies: Employment (full or part-time) in for-profit entities |
| 250 | Assita | Emane | LASE Innovation: Employment (full- or part-time) |
| 253 | August | Avery | 3M (Multinational conglomerate company): Research Grants, Salary Support, in-kind support |
| 87 | Bach | Maggie | Promega Corporation: Employment (full- or part-time) |
| 238 | Baker | Sherry | Biotheryx: Employment (full- or part-time) |
| 249 | Bali | Gunmeet Kaur | 10x Genomics Inc. : Employment (full- or part-time) |
| 246 | Baronas | April | Celldex Therapeutics: Employment (full- or part-time) |
| 146 | Barr | Paul | Merck, abbive, gilead, Beigene, Genentech, Astrazeneca, Janssen, TG therapeutics, Celgene, BMS, Morphosys, Adaptive: Consulting fees or other remuneration |
| 249 | Barrett | Crisha | Akadeum Life Sciences: Employment (full- or part-time) |
| 51 | Basak | Sayantani | Unanswered |
| 159 | Bass | Antonia | Merck & Co.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co.: Employment (full- or part-time) |
| 88 | Basu | Subham | Abcam: Employment (full- or part-time) |
| 166 | Basu Mallik | Sanchari | Alembic Pharmaceuticals Ltd.: Employment (full- or part-time) |
| 168 | Batchinsky | Andriy | Unanswered |
| 59 | Bauer | Rebecca | Genentech, Inc.: Employment (full- or part-time) |
| 222 | Beasley | Matthew | Myrio Tx: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 166 | Beilke | Joshua | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 171 | Ben Cheikh | Bassem | Akoya Biosciences: Employment (full- or part-time); Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 154 | Berg | Leslie | ImmVue: Ownership or partnership |
| 160 | Berrien-Elliott | Melissa | Wugen: Receipt of Royalties; Wugen: Consulting fees or other remuneration; Wugen: Ownership or partnership |
| 250 | Berry | Shannon | AKOYA Biosciences: Employment (full- or part-time) |
| 89 | Bertozzi | Carolyn | Palleon Pharmaceuticals,: cofounder and d Scientific Advisory Board member; Enable Bioscience: Member of a Scientific Advisory Group for a corporation; Redwood Biosciences: cofounder and d Scientific Advisory Board member; Eli Lilly & Company.: a member |
| 159 | Bett | Andrew | Merck & Co.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co.: Employment (full- or part-time) |
| 73 | Bhattacharya | Sam | BioLegend: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 89 | Bianchi | Marco | HMGBiotech: Ownership or partnership |
| 159 | Bjerkan | Louise | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 16 | Bjorkman | Pamela | Vir Biotechnology: Member of a Scientific Advisory Group for a corporation; California Institute of Technology: Inventor on patent applications filed by Caltech regarding nanoparticles in this work. |
| 173 | Blazar | Bruce | BlueRock Therapeutics: Consulting fees or other remuneration; Magenta Therapeutics: Consulting fees or other remuneration |
| 166 | Block | David | Gliknik: Employment (full- or part-time) |
| 238 | Bluestone | Jeffrey | Sonoma Biotherapeutics: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Sonoma Biotherapeutics: Employment (full- or part-time); Sonoma Biotherapeutics: Ownership or partnership; Sonoma Biotherapeutics: Positions |
| 250 | Blundell | Michael | Bio-Rad: Employment (full- or part-time) |
| 43 | Blundell | Mike | Bio-Rad Laboratories: Employment (full or part-time) in for-profit entities |
| 229 | Bonilla | Diana | Cytek Biosciences: Employment (full- or part-time) |
| 85 | Boster | Daniel | Mozart Therapeutics: Employment (full- or part-time) |
| 159 | Bøthun | Anne | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 250 | Bouzekri | Alexandre | Standard BioTools: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Standard BioTools: Employment (full- or part-time) |
| 251 | Bowers | Rita | Beckman Coulter: Employment (full- or part-time) |
| 85 | Bowser | Justin | Creatv Microtech, Inc.: Employment (full- or part-time) |
| 238 | Boyd-Kirkup | Jerome | Unanswered |
| 165 | Boyer | Olivier | Argenx: Research Grants, Salary Support, in-kind support; Argenx: Consulting fees or other remuneration; BMS: Consulting fees or other remuneration; CSL Behring: Research Grants, Salary Support, in-kind support; CSL Behring: Consulting fees or other remun |
| 246 | Boyer | James | Celldex Therapeutics: Employment (full- or part-time) |
| 166 | Boyne | Michael | Cour Pharmaceuticals: Employment (full- or part-time) |
| 171 | Braubach | Oliver | Akoya Biosciences: Employment (full- or part-time); Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 59 | Bräutigam | Manuel | Oncimmune Germany GmbH: Employment (full- or part-time) |
| 71 | Brestoff | Jonathan | LUCA Science, Inc.: Member of a Scientific Advisory Group for a corporation |
| 251 | Brix | Liselotte | Immudex: Employment (full- or part-time) |
| 253 | broderick | Kate | Inovio: Employment (full- or part-time) |
| 172 | Brodeur | Scott | Janssen Research & Development, Inc. : Employment (full- or part-time) |
| 225 | Bryan | Keith | Christopher Hansen: Employment (full- or part-time) |
| 159 | Bucala | Richard | Quest Diagnostics: Research Grants, Salary Support, in-kind support |
| 59 | Budde | Petra | Oncimmune Germany GmbH: Employment (full- or part-time) |
| 87 | Cali | Jim | Promega Corporation: Employment (full- or part-time) |
| 246 | Califano | Danielle | Axion Biosystems: Employment (full- or part-time) |
| 159 | Campbell | Elliot | Macrotope, Inc.: Ownership or partnership; Macrotope, Inc.: Positions of influence such as officer, board member, trustee, spokesperson; Macrotope, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 165 | Campos | Sebastien | Pharmaron: Employment (full- or part-time) |
| 89 | Capozzoli | Benjamin | Denovix Inc.: Employment (full- or part-time) |
| 165 | Caravella | Justin | Nimbus Therapeutics: Employment (full- or part-time) |
| 249 | Carey | Maureen | Akadeum Life Sciences: Employment (full- or part-time) |
| 247 | Carlesso | Gianluca | astrazeneca: Employment (full- or part-time) |
| 79 | Carman | Christopher | Emulate: Employment (full- or part-time) |
| 165 | Carreiro | Samantha | Nimbus Therapeutics: Employment (full- or part-time) |
| 250 | Cashman | Siobhán | BD: Employment (full- or part-time) |
| 251 | Castro | Aaron | JPT Peptide Technologies: Employment (full- or part-time) |
| 79 | Cespedes | Adriana | Emulate: Employment (full- or part-time) |
| 16 | Chakraborty | Arup | Flagship Pioneering: Consulting fees or other remuneration; Apriori Bio: Positions of influence such as officer, board member, trustee, spokesperson; FL72: Positions of influence such as officer, board member, trustee, spokesperson |
| 251 | Chan | Rena | 10x Genomics: Employment (full- or part-time) |
| 246 | Chan | Leo | Nexcelom from PerkinElmer: Employment (full- or part-time) |
| 63 | Chand | Dhan | Agenus Inc. : Employment (full- or part-time) |
| 59 | Chandler | Scott | Roche: Employment (full- or part-time) |
| 251 | Chang | Rick | Unanswered |
| 159 | Chang | Soojeong | CELLID Co., Ltd.: Employment (full- or part-time) |
| 250 | Chang | Qing | Cytek Biosciences, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 218 | Chang | John | Takeda: Research Grants, Salary Support, in-kind support; Eli Lilly: Research Grants, Salary Support, in-kind support |
| 166 | Chase | Jack | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 238 | Chaurasia | Aparajita | Biotheryx: Employment (full- or part-time) |
| 159 | Chellappa | Stalin | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 85 | Chen | Alex | Unanswered |
| 79 | Chen | Weihao | Biolegend: Employment (full- or part-time) |
| 246 | chen | Jingyi | Cytek Biosciences, Inc: Employment (full- or part-time) |
| 155 | Chen | Zhong | Gempharmatech ltd: Employment (full- or part-time) |
| 155 | Chen | Yingjiao | gempharmatech ltd: Employment (full- or part-time) |
| 250 | Chen | Yi-Chun | GenomeFrontier: Employment (full- or part-time) |
| 246 | Chenchik | Alex | Cellecta, Inc.: Employment (full- or part-time) |
| 85 | Chicoine | Adam | GentiBio: Employment (full- or part-time) |
| 171 | Chihab | Leila | NSF GRFP: Research Grants, Salary Support, in-kind support |
| 85 | Childs | Monica | Unanswered |
| 238 | Chin | Wen Jie | Unanswered |
| 245 | Chiocca | E. Antonio | Amacathera: Member of a Scientific Advisory Group for a corporation; Bionaut Labs: Member of a Scientific Advisory Group for a corporation; Genneta Inc.: Member of a Scientific Advisory Group for a corporation; Synthetics Biologics: Member of a Scientific |
| 73 | Chou | Lisa | BioLegend: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 89 | Chu | Charles C. | Acerta/AstraZeneca: Research Grants, Salary Support, in-kind support; GenMab: Research Grants, Salary Support, in-kind support; Pzifer: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; TG Therapeutics: Research Gra |
| 235 | Chu | Helen | Ellume: Consulting fees or other remuneration; The Bill and Melinda Gates Foundation: Consulting fees or other remuneration; Glaxo Smith Kline: Consulting fees or other remuneration; Janssen: Consulting fees or other remuneration; Merck: Consulting fees o |
| 146 | Chu | Charles | Pfizer: Current equity holder in publicly-traded company; Acerta / AstraZeneca: Research Grants, Salary Support, in-kind support; TG Therapeutics: Research Grants, Salary Support, in-kind support; Genmab: Research Grants, Salary Support, in-kind support |
| 176 | Chung | Pei-Han | Unanswered |
| 246 | Chvatal | Stacie | Axion Biosystems: Employment (full- or part-time) |
| 238 | Cianci | Mike | Seismic Therapeutic: Employment (full- or part-time) |
| 85 | Cipoletta | Daniela | Seismic: Employment (full- or part-time) |
| 238 | Cipolletta | Daniela | Seismic Therapeutic: Employment (full- or part-time) |
| 88 | Circelli | Jacob | Akoya Bioscience: Employment (full- or part-time) |
| 16 | Cohen | Alexander | California Institute of Technology: Inventor on patent applications filed by Caltech regarding nanoparticles in this work. |
| 250 | Cohen | Michael | Standard BioTools: Employment (full- or part-time); Standard BioTools: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 243 | Connelly | Stephen | Equillium Inc.: Positions of influence such as officer, board member, trustee, spokesperson |
| 166 | Cortez | Jessica | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 85 | Crane | Courtney | Mozart Therapeutics: Employment (full- or part-time) |
| 79 | Crawford | Kathryn | Allysta Pharmaceuticals: Employment (full- or part-time) |
| 37 | Criado-Moronati | Elvira | Miltenyi Biotec B.V. & Co. KG: Employment (full or part-time) in for-profit entities |
| 169 | Crittenden | Marka | Bristol Myers-Squibb: Research funding unrelated to this project and abstract; VIR Biotechnology: Research funding unrelated to this project and abstract; Roche: Consultancy unrelated to this project and abstract; Jounce Therapeutics: Research funding unr |
| 246 | Crocker | Andrea | Celldex Therapeutics: Employment (full- or part-time) |
| 250 | Croteau | Josh | PerkinElmer: Employment (full- or part-time) |
| 245 | Cuadrado-Castano | Sara | Patent: patent to APMV and Uses Thereof for The Treatment of Cancer pending and licensed |
| 246 | Cummings | James | Vaxart: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Vaxart: Employment (full- or part-time) |
| 250 | D’Cruz | Louise | Becton Dickinson Biosciences: Employment (full- or part-time) |
| 245 | Daftarian | Pirouz | JSR Life Sciences: Employment (full- or part-time) |
| 159 | Dangizer | Andrew | Merck & Co.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co.: Employment (full- or part-time) |
| 115 | Daniel | Dylan L. | CytomX Therapeutics, Inc.: Stock, stock options, or bond holdings in a for-profit corporation directly held or indirectly held within a self-directed pension, Employment (full or part-time) in for-profit entities plan |
| 223 | Davies | Jenny | MyImmunome Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 221 | Delcommenne | Marc | MBL International: Employment (full- or part-time) |
| 165 | Demarco | Kevin | Schrodinger, Inc.: Employment (full- or part-time) |
| 246 | Deng | Jun | Cytek Biosciences: Employment (full- or part-time) |
| 85 | Depis | Fabien | GentiBio: Employment (full- or part-time) |
| 84 | DeRyckere | Deborah | Meryx, Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 51 | Deshpande | Sonali | Advanced Cell Diagnostics, a Bio-Techne brand: Employment (full- or part-time) |
| 85 | DeVault | Victoria | GentiBio: Employment (full- or part-time) |
| 250 | Di Carlo | Dino | Partillion Bioscience: Positions of influence such as officer, board member, trustee, spokesperson |
| 146 | Diaz | Daniel | parse biosciences: Employment (full- or part-time) |
| 246 | Diehl | Paul | Cellecta, Inc.: Employment (full- or part-time) |
| 249 | Dikshit | Anushka | Bio-Techne: Employment (full- or part-time) |
| 165 | DiMattia | Michael | Schrodinger, Inc.: Employment (full- or part-time) |
| 79 | Divekar | Anagha | Biolegend: Employment (full- or part-time) |
| 250 | Dobrowolski | Marek | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 85 | Doherty | Abigail | GentiBio: Employment (full- or part-time) |
| 132 | Dong | Yi | Takeda Development Center Americas, Inc: Research Grants, Salary Support, in-kind support |
| 249 | Doolittle | Emerald | Advanced Cell Diagnostics: Employment (full- or part-time) |
| 249 | Doyle | Kristin | Fortis Life Sciences: Employment (full- or part-time) |
| 38 | Dragich | Joanna | Luminex Corporation: Employment (full or part-time) in for-profit entities |
| 257 | Drakaki | Alexandra | Bristol-Myers Squibb: Consulting fees or other remuneration; AstraZeneca: Consulting fees or other remuneration; Radmetrix: Consulting fees or other remuneration; Seattle Genetics: Consulting fees or other remuneration; Janssen: Consulting fees or other r |
| 251 | Drosch | Michael | JPT Peptide Technology, GmbH: Employment (full- or part-time) |
| 41 | Druge | Jonathan | Miltenyi Biotec B.V. & Co. KG: Employment (full or part-time) in for-profit entities |
| 250 | Duerrschmid | Clemens | AKOYA Biosciences: Employment (full- or part-time) |
| 26 | Duerrschmid | Clemens | Akoya Biosciences, Inc.: Stock, stock options, or bond holdings in a for-profit corporation directly held or indirectly held within a self-directed pension plan, Employment (full or part-time) in for-profit entities |
| 122 | Durkin | Amanda | STEMCELL Technologies Inc.: Employment (full or part-time) in for-profit entities |
| 159 | Dürkoop | Mirjam | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 143 | Dwyer | Connor | Werewolf Therapeutics: Employment (full- or part-time) |
| 200 | E. Lunsford MD, PhD, FACS | Keri | Unanswered |
| 84 | Earp | H. Shelton | Meryx, Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Meryx, Inc: Ownership or partnership |
| 159 | Ebert | Peter | Adaptive Biotechnologies Corp.: Employment (full- or part-time) |
| 251 | Eckey | Maren | JPT Peptide Technology, GmbH: Employment (full- or part-time) |
| 165 | Eckstein | Anja | Sling therapeutics : Research Grants, Salary Support, in-kind support |
| 246 | Edinger | Mark | Cytek Biosciences, Inc: Employment (full- or part-time) |
| 166 | Elhofy | Adam | Cour Pharmaceuticals: Employment (full- or part-time) |
| 250 | Elia | Jeanne | PerkinElmer: Employment (full- or part-time) |
| 249 | Ellis | Jason | Akadeum Life Sciences: Employment (full- or part-time) |
| 250 | Ellis | Samantha | Thermo Fisher Scientific: Employment (full- or part-time) |
| 238 | Erdman | Paul | Biotheryx: Employment (full- or part-time) |
| 79 | Ewart | Lorna | Emulate: Employment (full- or part-time) |
| 250 | Fahlberg | Marissa | LASE Innovation Inc.: Employment (full- or part-time) |
| 249 | Fails | Danielle | Fortis Life Sciences: Employment (full- or part-time) |
| 169 | fan | Jialu | gempharmatech: Employment (full- or part-time) |
| 173 | Farr | George | Aeromics: Employment (full- or part-time) |
| 85 | Fasnacht | Rachael | Mozart Therapeutics: Employment (full- or part-time) |
| 160 | Fehniger | Todd | Wugen: Receipt of Royalties; HCW Biologics: Research Grants, Salary Support, in-kind support; ImmunityBio: Research Grants, Salary Support, in-kind support; Wugen: Research Grants, Salary Support, in-kind support; Wugen: Consulting fees or other remunerat |
| 223 | Felgner | Jiin | MyImmunome Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 249 | Fernandes | Sunjay | 10x Genomics Inc. : Employment (full- or part-time) |
| 166 | Fiebiger | Benjamin | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 249 | Finnegan | Peter | 10x Genomics Inc. : Employment (full- or part-time) |
| 88 | Fisher | Jeremy | Cell Signaling Technology (CST): Employment (full- or part-time) |
| 85 | Fitzpatrick | Kristin | Mozart Therapeutics: Employment (full- or part-time) |
| 250 | Fleming | Chris | Cytek Biosciences: Employment (full- or part-time) |
| 250 | Fong | Nicolas | PerkinElmer: Employment (full- or part-time) |
| 51 | Fortes | Gabrielle | Emulate Bio: Employment (full- or part-time) |
| 250 | Forward | Sarah | LASE Innovation: Employment (full- or part-time) |
| 250 | Franco Nitta | Carolina | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 159 | Fredriksen | Agnete | Nykode Therapeutics ASA: Employment (full- or part-time); Nykode Therapeutics ASA: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Nykode Therapeutics ASA: Positions of influence such as officer, board member, tru |
| 51 | Frischmann | Amanda | Emulate Bio: Employment (full- or part-time) |
| 59 | Früh | Klaus | Vir Biotechnology: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Vir Biotechnology: Receipt of Royalties; Vir Biotechnology: Consulting fees or other remuneration; Vir Biotechnology: Member of a Scientific Advis |
| 22 | Fry | Terry | Sana Biotechnology: Employment (full- or part-time) |
| 84 | Frye | Stephen | Meryx, Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Meryx, Inc: Ownership or partnership |
| 250 | Fukazawa | Yoshinori | Cytek Biosciences. Inc: Employment (full- or part-time) |
| 238 | Fung | Leah | Biotheryx: Employment (full- or part-time) |
| 158 | García-Sastre | Adolfo | Pzer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma and Merck: Research Grants, Salary Support, in-kind suppo |
| 85 | Gardell | Jennifer | Unanswered |
| 146 | Gardner | Kirby | Creatv Microtech, Inc.: Employment (full- or part-time) |
| 245 | Georgiou | George | TXbiologics: Member of a Scientific Advisory Group for a corporation |
| 85 | Gilbertson | Emily | Unanswered |
| 146 | Gimlin | Susanne | Boehringer Ingelheim Pharmaceuticals Inc: Employment (full- or part-time) |
| 243 | Giovannone | A.J. | Equillium Inc.: Employment (full- or part-time) |
| 165 | Goertz | Gina-Eva | Sling therapeutics : Research Grants, Salary Support, in-kind support |
| 245 | Goins | William | Oncorus Inc: Consulting fees or other remuneration |
| 218 | Goldrath | Ananda | ArsenalBio: Member of a Scientific Advisory Group for a corporation |
| 246 | Goldstein | Joel | Celldex Therapeutics: Employment (full- or part-time) |
| 145 | Golovato | Justin | SagittariusBio: Employment (full- or part-time) |
| 246 | Gottlieb | Keith | vaxart: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Vaxart: Employment (full- or part-time) |
| 169 | Gough | Michael | Bristol Myers-Squibb: Research funding unrelated to this project and abstract; VIR Biotechnology: Research funding unrelated to this project and abstract; Jounce Therapeutics: Research funding unrelated to this project and abstract; Mavupharma: Research f |
| 245 | Goverse | Gera | Crown Bioscience: Employment (full- or part-time) |
| 238 | Goydel | Rebecca | Seismic Therapeutic: Employment (full- or part-time) |
| 84 | Graham | Douglas | Meryx, Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Meryx, Inc: Ownership or partnership |
| 159 | Granum | Stine | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 75 | Grayson | Mitchell | Inversa: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; AbbVie, GSK, and Merck: Member of a Scientific Advisory Group for a corporation |
| 251 | Grazia | Giulia | Beckman Coulter: Employment (full- or part-time) |
| 238 | Grebinoski | Stephanie | Seismic Therapeutic: Employment (full- or part-time) |
| 246 | Greco | Susan | Vaxart: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Vaxart: Employment (full- or part-time) |
| 238 | Green | Tobias | Seismic Therapeutic: Employment (full- or part-time) |
| 142 | Greenberg | Philip | Lonza: Research Grants, Salary Support, in-kind support |
| 238 | Greene | Steven | Biotheryx: Employment (full- or part-time) |
| 249 | Grimley | Edward | Akadeum Life Sciences: Employment (full- or part-time) |
| 63 | Grossman | Joseph | Agenus Inc. : Employment (full- or part-time) |
| 165 | Gulbins | Anne | Sling therapeutics: Research Grants, Salary Support, in-kind support |
| 250 | Gundimeda | Srinivas | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 145 | Gunn | Michael | Myeloid Therapeutics: Member of a Scientific Advisory Group for a corporation |
| 169 | Guo | Shiying | gempharmatech: Employment (full- or part-time) |
| 251 | Gupta | Anushka | 10x Genomics: Employment (full- or part-time) |
| 251 | Gutgasell | Lauren | 10x Genomics: Employment (full- or part-time) |
| 246 | Gutierrez | Samanta | Vaxart: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Vaxart: Employment (full- or part-time) |
| 86 | Guzman | Monica | BridgeMedicines: Research Grants, Salary Support, in-kind support; SeqRX: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 135 | Hacohen | Nir | Nykode Therapeutics ASA: Employment (full- or part-time); Related Sciences/Danger Bio: Consulting fees or other remuneration |
| 166 | Halle | Mahesh | Alembic Pharmaceuticals Ltd. : Employment (full- or part-time) |
| 165 | Hammer | Gary | Sling therapeutics: Research Grants, Salary Support, in-kind support |
| 251 | Hansen | Bjarke | Immudex: Employment (full- or part-time) |
| 238 | Hanson | Brendon | Unanswered |
| 243 | Harbison | Carole | Takeda: Employment (full- or part-time) |
| 146 | Hariadi | Bryan | parse biosciences: Employment (full- or part-time) |
| 250 | He | Yan | AKOYA Biosciences: Employment (full- or part-time) |
| 230 | Hekim | Can | Orion Therapeutics: Employment (full- or part-time) |
| 250 | Hem | Sopaul | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 51 | Heng | Anthony | Emulate Bio: Employment (full- or part-time) |
| 85 | Hermansky | Gleda | Mozart Therapeutics: Employment (full- or part-time) |
| 251 | Hermes | Alex | 10x Genomics: Employment (full- or part-time) |
| 249 | Hernandez | Alyssa | Fortis Life Sciences: Employment (full- or part-time) |
| 246 | Hernandez | Charles | Nexcelom from PerkinElmer: Employment (full- or part-time) |
| 146 | Herne | Christine | AstraZeneca: Research Grants, Salary Support, in-kind support; TG Therapeutics: Research Grants, Salary Support, in-kind support; Genmab: Research Grants, Salary Support, in-kind support |
| 250 | Hipol | Art-Danniel | PerkinElmer: Employment (full- or part-time) |
| 238 | Ho | Patrick | Sonoma Biotherapeutics: Research Grants, Salary Support, in-kind support |
| 235 | Hogrefe | Wayne | Aalto Bioreagents, Ltd.: Consulting fees or other remuneration |
| 251 | Holenya | Pavlo | JPT Peptide Technologies, GmbH: Employment (full- or part-time) |
| 85 | Hollfelder | Melissa | Seismic: Employment (full- or part-time) |
| 85 | Honjo | Tasuku | Meiji Seika Pharma Co.,Ltd.: Patent application |
| 250 | Horstman | Sheryl | ThermoFisher Scientific: Employment (full- or part-time) |
| 165 | Horstmann | Mareike | Sling therapeutics : Research Grants, Salary Support, in-kind support |
| 89 | Hou | Huanhuan | gempharmatech: Employment (full- or part-time) |
| 246 | Hu | Dongfang | Cellecta, Inc.: Employment (full- or part-time) |
| 250 | Hua | Wei-Kai | GenomeFrontier: Employment (full- or part-time) |
| 253 | Huang | Weishan | MegaRobo Technologies Corporation: Research Grants, Salary Support, in-kind support |
| 249 | Huang | Yongyang | Nexcelom Bioscience: Employment (full- or part-time) |
| 72 | Huggins | Richard | Immune Tolerance Network: Research Grants, Salary Support, in-kind support |
| 171 | Hughes | Brett | Merck Sharpe and Dohme: Member of a Scientific Advisory Group for a corporation; Bristol Myers Squibb, Astra Zeneca: Member of a Scientific Advisory Group for a corporation; Pfizer: Member of a Scientific Advisory Group for a corporation; Takeda: Member o |
| 246 | Hui | Daniel | Resilience: Employment (full- or part-time) |
| 253 | Humeau | Laurent | Inovio: Employment (full- or part-time) |
| 159 | Husbyn | Hannah | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 243 | Hwang | Joseph | MilliporeSigma: Employment (full- or part-time) |
| 67 | Hyo Jin | Kim | Ministry of Education (2019R1A6A1A10072987): Research Grants, Salary Support, in-kind support |
| 81 | Hyöty | Heikki | Uute Scientific LtD: Positions of influence such as officer, board member, trustee, spokesperson |
| 2 | Iannacone | Matteo | Gilead Sciences: Member of a Scientific Advisory Group for a corporation; Roche: Member of a Scientific Advisory Group for a corporation; Third Rock Ventures: Consulting fees or other remuneration; Amgen: Consulting fees or other remuneration; Allovir: Co |
| 250 | Ihley | Nicholas | AKOYA Biosciences: Employment (full- or part-time) |
| 251 | Inekci | Dilek | Immudex: Employment (full- or part-time) |
| 238 | Ingram | Piers | Unanswered |
| 238 | Ishihara | Jun | HeioThera Inc: Positions of influence such as officer, board member, trustee, spokesperson |
| 252 | Ito | Toshihiro | Biometrics Sympathies Inc.: Research Grants, Salary Support, in-kind support |
| 166 | Iyer | Abishek | Alembic Pharmaceuticals Ltd. : Employment (full- or part-time) |
| 165 | Jacques | Suzanne | Nimbus Therapeutics: Employment (full- or part-time) |
| 251 | Jaffee | Elizabeth | Dr Jaffee reports other support from Abmeta and Adventris, personal fees from Achilles, Dragonfly, Mestag, The Medical Home Group, Bluedot, and Surgtx, other support from Parker Institute, grants and other support from Lustgarten Foundation, grants and ot |
| 223 | Jain | Aarti | MyImmunome Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 226 | Jarjour | Nicholas | Damon Runyon postdoctoral fellowship DRG 2427-21: Research Grants, Salary Support, in-kind support |
| 246 | Jegede | Clara | Vaxart: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Vaxart: Employment (full- or part-time) |
| 88 | Jensen | Samuel | Cell signaling: Employment (full- or part-time) |
| 252 | Jensen | Jamie | MilliporeSigma: Employment (full- or part-time) |
| 159 | Jeon | Ju | ARV Technologies: Employment (full- or part-time) |
| 171 | Jhaveri | Niyati | Akoya Biosciences: Employment (full- or part-time); Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 8 | Jhaveri | Niyati | Akoya Biosciences, Inc.: Stock, stock options, or bond holdings in a for-profit corporation directly held or indirectly held within a self-directed pension plan, Employment (full or part-time) in for-profit entities |
| 249 | Ji | HaYeun | Akoya Biosciences: Employment (full- or part-time) |
| 249 | Joglekar | Alok | Mitsubishi-Tanabe Pharma: Research Grants, Salary Support, in-kind support |
| 132 | Johnson | Blake | Takeda Development Center Americas, Inc: Research Grants, Salary Support, in-kind support |
| 59 | Johnson | Susan | VaxArt, Inc.: Employment (full- or part-time) |
| 159 | Jørgensen | Marthe | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 237 | Ju | Cunxiang | gempharmatech: Employment (full- or part-time) |
| 85 | Julien | Susan | Mozart Therapeutics: Employment (full- or part-time) |
| 159 | Jung | In Kyung | CELLID Co., Ltd.: Employment (full- or part-time) |
| 246 | Ka | Mignane | Reslience: Employment (full- or part-time) |
| 165 | Kaila | Neelu | Nimbus Therapeutics: Employment (full- or part-time) |
| 51 | Kajula | Ville | Emulate Bio: Employment (full- or part-time) |
| 251 | Kamath | Govinda | 10x Genomics: Employment (full- or part-time) |
| 79 | Kanellias | Marianne | Emulate: Employment (full- or part-time) |
| 159 | Kang | Chang-Yuil | CELLID Co., Ltd.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; CELLID Co., Ltd.: Employment (full- or part-time) |
| 154 | Kang | Joonsoo | ImmVue: Ownership or partnership |
| 159 | Kang | Insoo | Quest Diagnostics: Research Grants, Salary Support, in-kind support |
| 251 | Kapinsky | Michael | Beckman Coulter: Employment (full- or part-time) |
| 166 | Kapure | Jeevak | Alembic Pharmaceuticals Ltd.: Employment (full- or part-time) |
| 88 | Kassim | Yasmin | Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Akoya Biosciences: Employment (full- or part-time) |
| 79 | Kassmer | Susannah | Biolegend: Employment (full- or part-time) |
| 166 | Kegler | Peter | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 246 | Keler | Tibor | Celldex Therapeutics: Employment (full- or part-time) |
| 167 | Keller | Alexandra | National Institutes of Health: Research Grants, Salary Support, in-kind support |
| 227 | Kemter | Andrea | ALK-Abello: Employment (full- or part-time) |
| 249 | Kennedy Darling | Julia | Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Akoya Biosciences: Employment (full- or part-time) |
| 251 | Kenney | John | Antibody Solutions: Employment (full- or part-time) |
| 160 | Keogh | Michael-Christopher | Epicypher: Employment (full- or part-time); Epicypher: Positions of influence such as officer, board member, trustee, spokesperson |
| 251 | Kern | Florian | JPT Peptide Technology, GmbH: Employment (full- or part-time) |
| 251 | Keshner | Emily | Unanswered |
| 250 | Kessel | Sarah | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 222 | Kiefel | Ben | Myrio Tx: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 250 | Kim | Jason | Unanswered |
| 51 | Kim | Ge-Ah | Advanced Cell Diagnostics, a Bio-Techne brand: Employment (full- or part-time) |
| 243 | Kim | James | Alembic Pharmaceuticals Ltd.: Employment (full- or part-time) |
| 159 | Kim | Jong Heon | CELLID Co., Ltd.: Employment (full- or part-time) |
| 250 | Kim | HyunSeok | IVIM Technology: Employment (full- or part-time) |
| 250 | Kim | Alex | IVIM Technology: Employment (full- or part-time) |
| 171 | Kim | Jieun | MedGene Therapeutics Co, Ltd: Research Grants, Salary Support, in-kind support |
| 146 | Kim | Grace | parse biosciences: Employment (full- or part-time) |
| 245 | Kleiman | Eden | Crown Bioscience: Employment (full- or part-time); JSR Life Sciences: Employment (full- or part-time) |
| 159 | Klinger | Mark | Adaptive Biotechnologies Corp.: Employment (full- or part-time) |
| 8 | Klymyshyn | Dmytro | Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Akoya Biosciences: Employment (full- or part-time) |
| 251 | Knaute | Tobias | JPT Peptide Technologies, GmbH: Employment (full- or part-time) |
| 246 | Kobzik | Lester | ARV Technologies: Employment (full- or part-time) |
| 249 | Koehler | Ryan | Parse Biosciences: Employment (full- or part-time) |
| 154 | Kolli | Nilima | ImmVue: Research Grants, Salary Support, in-kind support |
| 165 | Kollman | Justin | Nimbus Therapeutics: Research Grants, Salary Support, in-kind support |
| 75 | Kraft | Monica | Chiesi: Research Grants, Salary Support, in-kind support; Sanofi: Research Grants, Salary Support, in-kind support; Astra-Zeneca: Research Grants, Salary Support, in-kind support; Chiesi: Consulting fees or other remuneration; Sanofi: Consulting fees or o |
| 165 | Kreutter | Kevin | Nimbus Therapeutics: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 249 | Krishnan | Sreenath | 10x Genomics Inc.: Employment (full- or part-time) |
| 251 | Krishnaswamy | Smita | AI Therapeutics: Member of a Scientific Advisory Group for a corporation |
| 249 | Ku | Chia | Akadeum Life Sciences: Employment (full- or part-time) |
| 155 | Ku | Cunxiang | gempharmatech ltd: Employment (full- or part-time) |
| 159 | Kuczkowska | Katarzyna | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 59 | Kuebler | Peter | Roche: Employment (full- or part-time) |
| 79 | Kujala | Ville | Emulate: Employment (full- or part-time) |
| 250 | Kuksin | Dmitry | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 249 | Kumar | Poornasree | 10x Genomics Inc. : Employment (full- or part-time) |
| 165 | Kumar | Sheetal | Nimbus Therapeutics: Employment (full- or part-time) |
| 166 | Kuriappan | Jissy | Antibody Solutions: Employment (full- or part-time) |
| 250 | Kwok | Sheldon | Unanswered |
| 115 | L Daniel | Dylan | CytomX Therapeutics, Inc.: Stock, stock options, or bond holdings in a for-profit corporation directly held or indirectly held within a self-directed pension, Employment (full or part-time) in for-profit entities plan |
| 224 | LaBresh | Joanna | Unanswered |
| 251 | Lacaille | Vashti | Beckman Coulter: Employment (full- or part-time) |
| 238 | Lai | Chon | Biotheryx: Employment (full- or part-time) |
| 251 | Lambert | Jeremy | Quanterix: Employment (full- or part-time) |
| 155 | Lambris | John | Amyndas Pharmaceuticals: Ownership or partnership; Apellis Pharmaceuticals: Receipt of Royalties; Apellis Pharmaceuticals: Receipt of Royalties |
| 159 | Langston | Laura | ARV Technologies: Employment (full- or part-time) |
| 132 | Larman | Tatianna | Takeda Development Center Americas, Inc: Research Grants, Salary Support, in-kind support |
| 243 | Lazar | Dan | Promega: Employment (full- or part-time) |
| 127 | Le A. Roberts | Heaven | Thermo Fisher Scientific: Employment (full or part-time) in for-profit entities |
| 75 | Ledford | Julie | RaeSedo Inc: CSO |
| 238 | Lee | Warren | Unanswered |
| 171 | Lee | Sungkyu | MedGene therapeutics Co, Ltd: Research Grants, Salary Support, in-kind support |
| 87 | Leippe | Donna | Promega Corporation: Employment (full- or part-time) |
| 88 | LeungLee | Paulina | Cell Signaling: Employment (full- or part-time) |
| 63 | Levey | Daniel | Agenus Inc.: Employment (full- or part-time) |
| 173 | Levings | Megan | Sangamo: Receipt of Royalties |
| 237 | Li | Zhiying | gempharmatech: Employment (full- or part-time) |
| 169 | Li | Shuai | gempharmatech: Employment (full- or part-time) |
| 85 | Li | Xiang | GentiBio: Employment (full- or part-time) |
| 132 | Li | Rong | Takeda Development Center Americas, Inc: Research Grants, Salary Support, in-kind support |
| 155 | Liang | Juan | gempharmatech ltd: Employment (full- or part-time) |
| 72 | Liao | Wilson | Leo: Research Grants, Salary Support, in-kind support; Novartis: Research Grants, Salary Support, in-kind support; Pfizer: Research Grants, Salary Support, in-kind support; Regeneron: Research Grants, Salary Support, in-kind support; TRex Bio: Research Gr |
| 61 | Lieberman | Linda | Unanswered |
| 246 | Lillquist | Jay | Celldex Therapeutics: Employment (full- or part-time) |
| 72 | Lim | Henry | Pierre Fabre: Consulting fees or other remuneration; ISDIN: Consulting fees or other remuneration; La-Roche Posay: Consulting fees or other remuneration; Cantabria: Consulting fees or other remuneration; Beiersdorf: Consulting fees or other remuneration |
| 249 | Lim | Liang | Standard BioTools: Employment (full- or part-time); Standard BioTools (formerly Fluidigm): Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 245 | Lin | Wenbin | Coordination Pharmaceuticals: Ownership or partnership |
| 160 | Lin | Carolina | EpiCypher: Employment (full- or part-time) |
| 249 | Lin | Bo | Nexcelom Bioscience from PerkinElmer: Employment (full- or part-time) |
| 146 | Lin | Steven | Scenexo: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; AstraZeneca: Research Grants, Salary Support, in-kind support; BeyondSpring Pharma: Research Grants, Salary Support, in-kind support; Nektar: Research Grant |
| 62 | Lind | Evan | Janssen: Research Grants, Salary Support, in-kind support; Celgene: Research Grants, Salary Support, in-kind support; Monojul: Research Grants, Salary Support, in-kind support; Ikena Oncology: Research Grants, Salary Support, in-kind support; Kronos Bio,: |
| 159 | Lindahl | Torbjørn | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 155 | Liu | Qinglong | Unanswered |
| 88 | Liu | Linying | Akoya Bioscience: Employment (full- or part-time) |
| 246 | Liu | Tianbing | Cellecta, Inc.: Employment (full- or part-time) |
| 237 | Liu | gempharmatech: Employment (full- or part-time) | |
| 88 | Loebelenz | Jean | cell signaling: Employment (full- or part-time) |
| 250 | Loh | Christina | Standard BioTools: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Standard BioTools: Employment (full- or part-time) |
| 246 | Love | Andrea | Nexcelom from PerkinElmer: Employment (full- or part-time) |
| 235 | Lowman | Geoffrey | Thermo Fisher Scientific: Employment (full- or part-time) |
| 56 | Lueck | Kim | Thermo Fisher Scientific: Employment (full or part-time) in for-profit entities |
| 166 | Ly | Han | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 165 | Lynch | Eric | Nimbus Therapeutics: Research Grants, Salary Support, in-kind support |
| 171 | Ma | Ning | Akoya Biosciences: Employment (full- or part-time); Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 243 | Mahan | Sarah | Promega: Employment (full- or part-time) |
| 249 | Maheshwari | Shamoni | 10x Genomics Inc. : Employment (full- or part-time); 10x Genomics Inc. : Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 141 | Mahoney | Lauren | National Institutes of Health: Research Grants, Salary Support, in-kind support |
| 246 | Makhanov | Mikhail | Cellecta, Inc.: Employment (full- or part-time) |
| 246 | Malenchek | Linda | Celldex Therapeutics: Employment (full- or part-time) |
| 243 | Mamott | Daniel | Promega: Employment (full- or part-time) |
| 238 | Mande | Purvi | Seismic Therapeutic: Employment (full- or part-time) |
| 51 | Marianne | Marianne | Emulate Bio: Employment (full- or part-time) |
| 222 | Maris | John | Hula Therapeutics Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 50 | Markert | James | Catherex, Inc: received payments from structured buyout; Catherex was purchased by Amgen in 2015 and no longer exists; Aettis, Inc.: Receipt of Royalties; Treovir, Inc : Ownership or partnership; Imugene: Consulting fees or other remuneration; Mustang Bio |
| 243 | Marrocco | Valeria | Equillium Inc.: Employment (full- or part-time) |
| 246 | Marsh | Henry | Celldex Therapeutics: Employment (full- or part-time) |
| 222 | Marshall | Quinlen | PC-CAR Partners LLC: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 154 | Marson | Alexander | NewLimit: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; PACT Pharma: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; 23andMe: Consulting fees or other remuneration; Juno |
| 52 | Martin Esteban | Adrian | National Institutes of Health: Research Grants, Salary Support, in-kind support |
| 160 | Marunde | Matthew | Epicypher: Employment (full- or part-time) |
| 160 | Maryanski | Danielle | EpiCypher: Employment (full- or part-time) |
| 85 | Mascanfroni | Ivan | Seismic: Employment (full- or part-time) |
| 252 | Matsushima | Kouji | Kyowa-Hakko Kirin: Positions of influence such as officer, board member, trustee, spokesperson; ImmunoGeneTeqs, Inc: Positions of influence such as officer, board member, trustee, spokesperson; Kyowa-Hakko Kirin: Research Grants, Salary Support, in-kind s |
| 166 | Matthaei | James | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 146 | Matulich | Peter | parse biosciences: Employment (full- or part-time) |
| 85 | Mauer | Meghan | Unanswered |
| 85 | Maurer | Meghan | Mozart Therapeutics: Employment (full- or part-time) |
| 198 | McBain | Kirsty | Sartorius: Employment (full or part-time) in for-profit entities |
| 59 | McBride | Jacqueline | Genentech, Inc.: Employment (full- or part-time) |
| 165 | McElwee | Joshua | Nimbus Therapeutics: Employment (full- or part-time) |
| 173 | McGuirk | Paul | Aeromics Inc.: Employment (full- or part-time) |
| 166 | McKenzie | Brent | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 250 | McKitrick | Tanya | Thermo Fisher Scientific: Employment (full- or part-time) |
| 88 | McLane | Michael | Akoya Bioscience: Employment (full- or part-time) |
| 85 | McMahan | Catherine | Mozart Therapeutics: Employment (full- or part-time); mozart therapeutics: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 246 | McManus | Kelly | Celldex Therapeutics: Employment (full- or part-time) |
| 249 | McNaughton | Brandon | Akadeum Life Sciences: Employment (full- or part-time) |
| 85 | Meengs | Brent | Mozart Therapeutics: Employment (full- or part-time) |
| 247 | Meffre | Eric | AbbVie: Advisor |
| 250 | Mejia | Eunice | PerkinElmer: Employment (full- or part-time) |
| 166 | Mileur | Trevor | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 246 | Millard | Daniel | Axion Biosystems: Employment (full- or part-time) |
| 67 | Miller | Madelyn | Unanswered |
| 246 | Miller | Heather | Cytek biosciences: Employment (full- or part-time); Cytek biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 249 | Miller | Amber | Fortis Life Sciences: Employment (full- or part-time) |
| 6 | Miller | Lloyd | Immunology, Janssen Research and Development: Employment (full- or part-time); Johnson & Jonhson: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 246 | Mills-Chen | Laura | Celldex Therapeutics: Employment (full- or part-time) |
| 160 | Miyazaki | Yoshiyuki | Ventuno Co., LTD.: Research Grants, Salary Support, in-kind support; NPO Research Institute of Fucoidan: Research Grants, Salary Support, in-kind support |
| 85 | Mojta | Shanell | Seismic: Employment (full- or part-time) |
| 111 | Monasterio | Gustavo | CANOPY Biosciences: Other |
| 246 | Montanari | Noe | Celldex Therapeutics: Employment (full- or part-time) |
| 211 | Montoya | Leticia | Thermo Fisher Scientific: Stock, stock options, or bond holdings in a for-profit corporation directly held or indirectly held within a self-directed pension plan, Employment (full or part-time) in for-profit entities |
| 237 | Moore | Mark | gempharmatech: Employment (full- or part-time) |
| 246 | Moore | Andrea | Resilience: Employment (full- or part-time) |
| 85 | Morgan | Nadine | Unanswered |
| 122 | Morin | Peter | STEMCELL Technologies Inc.: Employment (full or part-time) in for-profit entities |
| 89 | Morrissey | Amanda | Charles River: Employment (full- or part-time) |
| 159 | Mou | Stephanie | ARV Technologies: Employment (full- or part-time) |
| 249 | Mousavi | Nima | 10x Genomics Inc. : Stock options or bond holdings in a for-profit corporation or self-directed pension plan; 10x Genomics Inc.: Employment (full- or part-time) |
| 250 | Mukherjee | Avik | AKOYA Biosciences: Employment (full- or part-time) |
| 68 | Murad | Joana | Unanswered |
| 246 | Murphy | Michael | Celldex Therapeutics: Employment (full- or part-time) |
| 166 | Murthy | Tushar | Cour Pharmaceuticals: Employment (full- or part-time) |
| 159 | Namouchi | Amine | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 167 | Nelson | Alissa | Cell Signaling Technology: Employment (full- or part-time) |
| 251 | Nelson | William | Tetracore: Ownership or partnership; Tetracore: Employment (full- or part-time); Tetracore: Positions of influence such as officer, board member, trustee, spokesperson |
| 238 | Neo | Jacklyn | Unanswered |
| 85 | Newton | Andita | Seismic: Employment (full- or part-time) |
| 243 | Ng | Cherie | Equillium Inc.: Employment (full- or part-time) |
| 250 | Nguyen | Chau | Thermo Fisher Scientific: Employment (full- or part-time) |
| 145 | Niazi | Kayvan | SagittariusBio: Employment (full- or part-time) |
| 73 | Nickle | Rebecca | BioLegend: Employment (full- or part-time); PerkinElmer: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 88 | NIKULINA | NADEZHDA | AKOYA BIOSCIENCES: Employment (full- or part-time); AKOYA BIOSCIENCES: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 235 | Noone | Philip | Aalto Bio Reagents, Ltd.: Positions of influence such as officer, board member, trustee, spokesperson |
| 159 | Norheim | Gunnstein | Nykode Therapeutics ASA: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Nykode Therapeutics ASA: Employment (full- or part-time) |
| 243 | O’Brien | Martha | Promega: Employment (full- or part-time) |
| 159 | O’Donnell | Gregory | Merck & Co.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co.: Employment (full- or part-time) |
| 246 | O’Neill | Thomas | Celldex Therapeutics: Employment (full- or part-time); Celldex Therapeutics: Employment (full- or part-time) |
| 259 | O’Sullivan | Timothy | Xyphos: Member of a Scientific Advisory Group for a corporation; Modulus: Member of a Scientific Advisory Group for a corporation |
| 103 | O’Sullivan | Timothy | Modulus Therapeutics: Consulting fees or other remuneration from for-profit entities. Xyphos Biosciences Inc.: Research grants, salary support, in-kind support from for-profit entities, Consulting fees or other remuneration from for-profit entities |
| 260 | O’Sullivan | Timothy | Los Angles (UCLA) – DGIT: Employment in for-profit entities, Modulus Therapeutics: Research grants, salary support, in-kind support from for-profit entities, Xyphos Biosciences, Inc. |
| 165 | Oeverhaus | Michael | Sling therapeutics: Research Grants, Salary Support, in-kind support |
| 159 | Oh | Jonghan | CELLID Co., Ltd.: Employment (full- or part-time) |
| 85 | Ohkura | Iori | Meiji Seika Pharma Co.,Ltd.: Employment (full- or part-time) |
| 85 | Ohta | Akio | Meiji Seika Pharma Co.,Ltd.: Research Grants, Salary Support, in-kind support; Meiji Seika Pharma Co.,Ltd.: Patent application |
| 166 | Olsen | Henrik | Gliknik: Employment (full- or part-time) |
| 59 | Onabajo | Olusegun | Genentech, Inc.: Employment (full- or part-time) |
| 238 | Orlandi | Chiara | Biotheryx.com: Employment (full- or part-time) |
| 159 | Osborne | Edward | Adaptive Biotechnologies Corp.: Employment (full- or part-time) |
| 153 | Oshiro | Yuya | Meiji Seika Pharma, Co., Ltd.: Employment (full- or part-time) |
| 146 | Oter | Gizem | Boehringer Ingelheim Pharmaceuticals inc: Employment (full- or part-time) |
| 59 | Otero | Claire | National CMV Foundation: Research Grants, Salary Support, in-kind support |
| 249 | Ouladan | Shaida | Standard BioTools: Employment (full- or part-time); Standard BioTools (formerly Fluidigm): Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 145 | Pack | Christopher | Metaclipse Therapeutics Corporation: Employment (full- or part-time) |
| 155 | Paley | Michael | AbbVie: Consulting fees or other remuneration; Lilly: Research Grants, Salary Support, in-kind support; Proviant Therapeutics: Consulting fees or other remuneration |
| 238 | Paliwal | Shalini | Hummingbird Bioscience: Employment (full- or part-time) |
| 249 | Papalexi | Efthymia | Parse Biosciences: Employment (full- or part-time) |
| 159 | Park | Hyemin | CELLID Co., Ltd.: Employment (full- or part-time) |
| 159 | Park | Seowoo | CELLID Co., Ltd.: Employment (full- or part-time) |
| 171 | Park | Yong | MedGene Therapeutics Co, Ltd: Ownership or partnership |
| 250 | Parker | Aiyana | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 246 | Passaro | Austin | Axion Biosystems: Employment (full- or part-time) |
| 238 | Paszkiewicz | Konrad | Unanswered |
| 251 | Patel | Anuj | 10x Genomics: Employment (full- or part-time) |
| 249 | Patel | Samir | Nexcelom from PerkinElmer: Employment (full- or part-time) |
| 246 | Patterson | Colleen | Celldex Therapeutics: Employment (full- or part-time) |
| 85 | Patton | Dan | Unanswered |
| 85 | Patton | Daniel | Mozart Therapeutics: Employment (full- or part-time) |
| 158 | Pearson | Ryan | National Institute of Health – R35GM142752 : Research Grants, Salary Support, in-kind support; Shock Society Faculty Research Award: Research Grants, Salary Support, in-kind support |
| 159 | Pedersen | Mikkel | Nykode Therapeutics ASA: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Nykode Therapeutics ASA: Employment (full- or part-time) |
| 75 | Peeples | Mark | Janssen and CyanVac: Research Grants, Salary Support, in-kind support |
| 90 | Pekna | Marcela | Merck KGaA: Consulting fees or other remuneration from for-profit entities, argenx: Member of a Scientific Advisory Group for a foundation or for-profit entity |
| 88 | Perez | Oscar | Akoya Bioscience: Employment (full- or part-time) |
| 75 | Permar | Sallie | Moderna: Consulting fees or other remuneration; Merck: Consulting fees or other remuneration; Pfizer: Consulting fees or other remuneration; GSK: Consulting fees or other remuneration; Dynavax: Consulting fees or other remuneration; Hoopika: Consulting fe |
| 52 | Peske | J. | National Institutes of Health: Research Grants, Salary Support, in-kind support |
| 251 | Pfeil | S | JPT Peptide Technologies, GmbH: Employment (full- or part-time) |
| 249 | Pfister | Thomas | Standard BioTools: Employment (full- or part-time); Standard BioTools (formerly Fluidigm): Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 165 | Phadke | Avinash | Nimbus Therapeutics: Employment (full- or part-time) |
| 85 | Pham | Minh | Vaxart, Inc.: Employment (full- or part-time) |
| 165 | Philipp | Svenja | Sling therapeutics : Research Grants, Salary Support, in-kind support |
| 246 | Phippard | Deborah | Unanswered |
| 166 | Phong | Brian | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 235 | Pickle | Loni | Thermo Fisher Scientific: Employment (full- or part-time) |
| 250 | Pierce | Mackenzie | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 79 | Pignalosa | Anglica | Allysta Pharmaceuticals: Employment (full- or part-time) |
| 221 | Poluektov | Yuri | MBL International: Employment (full- or part-time) |
| 197 | Poluektov | Yuri | MBL International Corporation: Employment (full or part-time) in for-profit entities |
| 223 | Pone | Egest | MyImmunome Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 252 | Poole | Brian | Merck Sharp & Dohme LLC: Research Grants, Salary Support, in-kind support |
| 171 | Pratapa | Aditya | Akoya Biosciences: Employment (full- or part-time); Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 88 | Prater | Michael | Abcam: Employment (full- or part-time) |
| 168 | Pugsley | Haley | Luminex Corporation: Employment (full- or part-time) |
| 250 | Qazi | Henry | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 159 | Qin | Jane | ARV Technologies: Employment (full- or part-time) |
| 145 | Rabizadeh | Shahrooz | SagittariusBio: Employment (full- or part-time) |
| 85 | Rachael | Fasnacht | Unanswered |
| 159 | Racke | Michael | Quest Diagnostics: Employment (full- or part-time) |
| 145 | Ramachandiran | Sampath | Metaclipse Therapeutics Corporation: Employment (full- or part-time) |
| 249 | Ramen | Nandhini | 10x Genomics Inc. : Employment (full- or part-time) |
| 166 | Ramsdell | Fred | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 250 | Ratnani | Surbhi | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 249 | Raza | Qanber | Standard BioTools: Employment (full- or part-time); Standard BioTools (formerly Fluidigm): Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 154 | Reboldi | Andrea | ImmVue: Ownership or partnership |
| 141 | Reddy | Sai | Alloy Therapeutics: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Alloy Therapeutics: Member of a Scientific Advisory Group for a corporation; Engimmune Therapeutics: Consulting fees or other remuneration |
| 145 | Reddy | Shaker | Metaclipse Therapeutics Corporation: Ownership or partnership |
| 91 | Rehermann | Barbara | NIDDK, National Institutes of Health, DHHS: Employment in for-profit entities, Journal of Hepatology, EASL: Positions of influence such as office, board member, trustee or spokesperson for a research foundation, non-profit or for-profit entity, Taconic Bi |
| 251 | Reimer | Ulf | JPT Peptide Technologies, GmbH: Employment (full- or part-time) |
| 249 | Reyes | Daniel | 10x Genomics Inc. : Employment (full- or part-time); 10x Genomics Inc. : Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 257 | Ribas | Antoni | Amgen: Consulting fees or other remuneration; Bristol-Myers Squibb: Consulting fees or other remuneration; Chugai: Consulting fees or other remuneration; Genetech: Consulting fees or other remuneration; Merck: Consulting fees or other remuneration; Novart |
| 259 | Riggan | Luke | ImmunoVec: Employment (full- or part-time) |
| 247 | Riggs | Jeff | astrazeneca: Employment (full- or part-time) |
| 32 | Rincon | Mercedes | Mitotherapeutix: Member of a Scientific Advisory Group for a corporation |
| 146 | Roco | Charles | parse biosciences: Ownership or partnership |
| 159 | Rodriguez | Silveria | Merck & Co.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co.: Employment (full- or part-time) |
| 146 | Rosenberg | Alexander | parse biosciences: Ownership or partnership |
| 233 | Rouphael | Nadine | Moderna: serve on Safety Advisory Board; NIH: receives funds to conduct clinical trials related to Pfizer BioNTech and Moderna |
| 249 | Roussey | Jon | Akadeum Life Sciences: Employment (full- or part-time) |
| 224 | Ruger | Lauren | Theraclion: Consulting fees or other remuneration |
| 250 | Ruiz | Jen | PerkinElmer: Employment (full- or part-time) |
| 251 | Russel | Spontaneous | 10x Genomics: Employment (full- or part-time) |
| 166 | Sachidanandam | Ravi | Girihlet Inc.: Employment (full- or part-time) |
| 172 | Samakai | Elsie | Janssen Research & Development : Employment (full- or part-time) |
| 250 | Sanderson | Sharon | Bio-Rad: Employment (full- or part-time) |
| 43 | Sanderson | Sharon | Bio-Rad: Employment (full or part-time) in for-profit entities |
| 85 | Sanmarco | Liliana | Seismic: Employment (full- or part-time) |
| 251 | Santiago | Ace | 10x Genomics: Employment (full- or part-time) |
| 251 | Santibanez-Vargas | Leonel | Unanswered |
| 235 | Sarda | Shrutii | Thermo Fisher Scientific: Employment (full- or part-time) |
| 251 | Sarwar | Jawad | Tetracore: Employment (full- or part-time) |
| 85 | Sassone-Corsi | Martina | GentiBio Inc. : Employment (full- or part-time) |
| 243 | Sato | Yosuke | Takeda: Employment (full- or part-time) |
| 160 | Satoyama | Toshiya | Ventuno Co., LTD.: Research Grants, Salary Support, in-kind support; NPO Research Institute of Fucoidan: Research Grants, Salary Support, in-kind support |
| 226 | Satpathy | Ansuman | Allogene Therapeutics: Research Grants, Salary Support, in-kind support; Merck Research Laboratories: Research Grants, Salary Support, in-kind support; Immunai: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Immu |
| 172 | Saunders | Ian | Janssen Research & Development, INC. : Employment (full- or part-time) |
| 88 | Schaefer | Rachel | Akoya Bioscience: Employment (full- or part-time) |
| 251 | Schnatbaum | Karsten | JPT Peptide Technology, GmbH: Employment (full- or part-time) |
| 251 | Schneider | Laura | Beckman Coulter: Employment (full- or part-time) |
| 250 | Schrantz | Nicolas | PerkinElmer: Employment (full- or part-time) |
| 146 | Schroeder | Sarah | parse biosciences: Employment (full- or part-time) |
| 67 | Schwartz | Daniella | Guidepoint consulting: Consulting fees or other remuneration |
| 159 | Secore | Susan | Merck & Co: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co: Employment (full- or part-time) |
| 159 | Sekelja | Monika | Nykode Therapeutics ASA: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Nykode Therapeutics ASA: Employment (full- or part-time) |
| 145 | Selvaraj | Periasamy | Metaclipse Therapeutics Corporation: Ownership or partnership |
| 171 | Seong | Rho | MedGeneTherapeutics, Ltd.: Research Grants, Salary Support, in-kind support |
| 194 | Shafee | Norazizah | Synbal Inc: Research Grants, Salary Support, in-kind support |
| 249 | Shahi | Payam | 10x Genomics Inc.: Employment (full- or part-time); 10x Genomics Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 238 | Shakya | Arvind | Biotheryx: Employment (full- or part-time) |
| 250 | Shang | Olive | AKOYA Biosciences: Employment (full- or part-time) |
| 137 | Sharpe | Arlene | Roche/Genentech Patents with royalties paid Novartis Patents with royalties paid Pfizer License with royalties Surface Oncology Scientific Advisory Board Sqz Biotech Scientific Advisory Board Selecta Scientific Advisory Board Monopteros Scientific Advisor |
| 243 | Shaw | Mike | Takeda: Employment (full- or part-time) |
| 250 | Shi | Xiaoshan | Becton Dickinson Biosciences: Employment (full- or part-time) |
| 252 | Shichino | Shigeyuki | ImmunoGeneTeqs, Inc.: Positions of influence such as officer, board member, trustee, spokesperson; ImmunoGeneTeqs, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 159 | Shin | Kwang-Soo | CELLID Co., Ltd.: Employment (full- or part-time) |
| 159 | Shin | Jieun | CELLID Co., Ltd.: Employment (full- or part-time) |
| 59 | Shrivastava | Divya | Roche Products Ltd: Employment (full- or part-time) |
| 145 | Sieling | Peter | SagittariusBio: Employment (full- or part-time) |
| 136 | Sims | Peter | Guardant Health : Receipt of Royalties; Epicypher : Consulting fees or other remuneration |
| 20 | Sindelar | Timothy | Canopy Biosciences: Employment (full or part-time) in for-profit entities |
| 251 | Singh | Hardeep | 10x Genomics: Employment (full- or part-time) |
| 81 | Sinkkonen | Aki | Uute Scientific LtD: Positions of influence such as officer, board member, trustee, spokesperson |
| 64 | Sitbon | Marc | METAFORA-Biosystems: Co-founder and head of scientific board |
| 159 | Skarshaug | Renate | Nykode Therapeutics ASA: Employment (full- or part-time) |
| 235 | Slifka | Mark | Najít Technologies, Inc: Positions of influence such as officer, board member, trustee, spokesperson; Najít Technologies, Inc: Research Grants, Salary Support, in-kind support; Najít Technologies, Inc: Ownership or partnership |
| 252 | Sloan-Aagard | Chantel | Merck Sharp & Dohme LLC: Research Grants, Salary Support, in-kind support |
| 246 | Smieszek | Sandra | Vanda Pharmaceuticals Inc.: Employment (full- or part-time) |
| 253 | Smith | Trevor | Inovio: Employment (full- or part-time) |
| 250 | Smith | Timothy | Nexcelom Bioscience: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 249 | Snow | Tiffany | Akadeum Life Sciences: Employment (full- or part-time) |
| 245 | Speers | Corey | Exact Sciences: Consulting fees or other remuneration |
| 249 | Spencer | Mike | Fortis Life Sciences: Employment (full- or part-time) |
| 165 | Spencer | Andrew | Sling therapeutics : Research Grants, Salary Support, in-kind support |
| 249 | Srinivasan | Maithreyan | Advanced Cell Diagnostics: Employment (full- or part-time) |
| 250 | Stalbaum | Kimberly | Thermo Fisher Scientific: Employment (full- or part-time) |
| 238 | Stanlie | Andre | Seismic Therapeutic: Employment (full- or part-time) |
| 65 | Sternberg | Luise | Thermo Fisher Scientific: Employment (full- or part-time) |
| 241 | Sterner | Rosalie | Humanigen: Receipt of Royalties |
| 167 | Stokes | Matthew | Cell Signaling Technology: Employment (full- or part-time) |
| 245 | Stone | Everett | TXbiologics: Member of a Scientific Advisory Group for a corporation |
| 246 | Streeter | Ben | Axion BioSystems: Employment (full- or part-time) |
| 166 | Strome | Scott | Gliknik, Inc.: Ownership or partnership |
| 159 | Stubsrud | Elisabeth | Nykode Therapeutics ASA: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Nykode Therapeutics ASA: Employment (full- or part-time) |
| 229 | Su | Helen | Pfizer: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Amgen: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Eli Lilly: Stock options or bond holdings in a for-profit co |
| 251 | Sukovich | David | 10x Genomics: Employment (full- or part-time) |
| 246 | Sullivan | Denise | Axion BioSystems: Employment (full- or part-time) |
| 159 | Sullivan | Nicole | Merck & Co: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co: Employment (full- or part-time) |
| 237 | Sun | Hongyan | gempharmatech: Employment (full- or part-time) |
| 250 | Sun | Yu-Jun | GenomeFrontier: Employment (full- or part-time) |
| 218 | Sung | Chi Chang | Moderna: Research Grants, Salary Support, in-kind support |
| 237 | Suryani Chen | Santi | GemPharmatech: Employment (full- or part-time) |
| 168 | Sutton | Alexandra | Luminex Corporation: Employment (full- or part-time) |
| 228 | Suzuki | Hiroaki | EA Pharma: Employment (full- or part-time) |
| 153 | Suzuki | Kensuke | Meiji Seika Pharma, Co., Ltd.: Employment (full- or part-time) |
| 79 | Sweeney | Gary | Allysta Pharmaceuticals: Research Grants, Salary Support, in-kind support |
| 85 | Swiderek | Kristine | Mozart Therapeutics: Employment (full- or part-time) |
| 250 | Swift | Teresa | Unanswered |
| 87 | Sylvester | Kayla | Promega Corporation: Employment (full- or part-time) |
| 73 | Tam | Miguel | BioLegend: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 85 | Tan | Cong | Unanswered |
| 166 | Tandon | Amol | Alembic Pharmaceuticals Ltd.: Employment (full- or part-time) |
| 146 | Tang | Cha Mei | Unanswered |
| 238 | Tang | Qizhi | Sonoma Biotherapeutics: Research Grants, Salary Support, in-kind support; Sonoma Biotherapeutics: Consulting fees or other remuneration; Sonoma Biotherapeutics: Ownership or partnership |
| 238 | Tay | Lavina | Unanswered |
| 250 | Taylor | Erin | Thermo Fisher Scientific: Employment (full- or part-time) |
| 249 | Terry | Jessica | 10x Genomics Inc. : Stock options or bond holdings in a for-profit corporation or self-directed pension plan; 10x Genomics Inc. : Employment (full- or part-time) |
| 238 | Thakkar | Dipti | Unanswered |
| 159 | Thambi | Nithya | Merck & Co.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co.: Employment (full- or part-time) |
| 85 | Therriault | Jon | Mozart Therapeutics: Employment (full- or part-time) |
| 253 | Thirion | Christian | Sirion Biotech: Positions of influence such as officer, board member, trustee, spokesperson |
| 246 | Thomas | Lawrence | Celldex Therapeutics: Employment (full- or part-time) |
| 250 | Thomas | Seddon | Thermo Fisher Scientific: Employment (full- or part-time) |
| 243 | Tiet | Phoi | Equillium Inc.: Employment (full- or part-time) |
| 153 | Tokumaru | Yosuke | Meiji Seika Pharma, Co., Ltd.: Employment (full- or part-time) |
| 165 | Toms | Angela | Nimbus Therapeutics: Employment (full- or part-time) |
| 155 | Tong | Huan | gempharmatech ltd: Employment (full- or part-time) |
| 235 | Toro | Michelle | Thermo Fisher Scientific: Employment (full- or part-time) |
| 166 | Torres | Josue | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 250 | Tracey | Lauren | Standard BioTools: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Standard BioTools: Employment (full- or part-time) |
| 246 | Tran | Kevin | Cytek biosciences, Inc: Employment (full- or part-time) |
| 146 | Tran | Vuong | parse biosciences: Employment (full- or part-time) |
| 166 | Trotta | Eleonora | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 158 | Truong | Nhu | PhRMA Foundation: Research Grants, Salary Support, in-kind support |
| 249 | Tsai | FuNien | 10x Genomics Inc. : Employment (full- or part-time) |
| 59 | Tucker | Sean | VaxArt, Inc.: Employment (full- or part-time) |
| 165 | Tummino | Peter | Nimbus Therapeutics: Employment (full- or part-time) |
| 235 | Turkoglu | Altan | Thermo Fisher Scientific: Employment (full- or part-time) |
| 252 | Ueha | Satoshi | IDAC Theranostics, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 79 | Ujagar | Naveena | Partillion Bioscience: Research Grants, Salary Support, in-kind support |
| 146 | Upchurch-Ange | Katherine | Boehringer-Ingelheim Phamaceutical Inc: Employment (full- or part-time) |
| 87 | Valley | Mike | Promega Corporation: Employment (full- or part-time) |
| 166 | Van Gool | Frédéric | Sonoma Biotherapeutics: Employment (full- or part-time) |
| 146 | VanDerMeid | Karl | Bausch and Lomb: Employment (full- or part-time) |
| 251 | Veire | Benton | 10x Genomics: Employment (full- or part-time) |
| 251 | Venkateswaran | Neeraja | Tetracore: Employment (full- or part-time) |
| 251 | Venkateswaran | Kodumudi | Tetracore: Employment (full- or part-time) |
| 165 | Verras | Andreas | Schrodinger, Inc.: Employment (full- or part-time) |
| 87 | Vidugiriene | Jolanta | Promega Corporation: Employment (full- or part-time) |
| 249 | Vignali | Dario | Novasenta: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Tizona: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Trishula: Stock options or bond holdings in a for-profit |
| 27 | Viney | Jo | Seismic Therapeutic: Employment (full- or part-time), Position of influence such as officer, board member, trustee or spokesperson for a research foundation, non-profit or for-profit entity. Former employee and officer of Pandion Therapeutics, Former empl |
| 218 | Vinot | Pierre-Axel | Sparingvision: Employment (full- or part-time) |
| 238 | Visweswaraiah | Jyothsna | Seismic Therapeutic: Employment (full- or part-time) |
| 246 | Vitale | Laura | Celldex Therapeutics: Employment (full- or part-time) |
| 224 | Vlaisavljevich | Eli | HistoSonics: Research partnership and Financial Relationship |
| 229 | Vogel | Tiphanie | Novartis: Consulting fees or other remuneration; Pfizer: Consulting fees or other remuneration; Moderna: Consulting fees or other remuneration; SOBI: Consulting fees or other remuneration |
| 243 | Walden | Zara | MilliporeSigma: Employment (full- or part-time) |
| 51 | Wang | Li-Chong | Advanced Cell Diagnostics, a Bio-Techne brand: Employment (full- or part-time) |
| 229 | Wang | Xiaoyang | Cytek Biosciences Inc: Employment (full- or part-time) |
| 250 | Wang | Alice | Cytek Biosciences: Employment (full- or part-time) |
| 237 | Wang | Huiyi | gempharmatech: Employment (full- or part-time) |
| 237 | Wang | Hongyu | gempharmatech: Employment (full- or part-time) |
| 84 | Wang | Xiaodong | Meryx, Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 246 | Wasiuk | Anna | Celldex Therapeutics: Employment (full- or part-time) |
| 146 | Wawro Weidanz | Debra | Resonant Sensors Inc: Employment (full- or part-time); Boehringer Ingelheim Pharmaceuticals Inc: Consulting fees or other remuneration |
| 249 | Wegner | Casey | Akadeum Life Sciences: Employment (full- or part-time) |
| 245 | Weichselbaum | Ralph | Boost Therapeutics, Immvira, Reflexion Pharmaceuticals, Coordination Pharmaceuticals, Magi Therapeutics and Oncosenescence: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Aettis, AstraZeneca, Coordination Pharmac |
| 146 | Weidanz | Jon | Boehringer Ingelheim Pharmaceuticals Inc: Consulting fees or other remuneration |
| 246 | Weidlick | Jeff | Celldex Therapeutics: Employment (full- or part-time) |
| 253 | Weiner | David | Inovio: Positions of influence such as officer, board member, trustee, spokesperson |
| 140 | Weinstein | Aliyah | Fortis Life Sciences: Employment (full or part-time) in for-profit entities |
| 251 | Weit | Nicole | Beckman Coulter GmbH: Employment (full- or part-time); Beckman Coulter Life Sciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 251 | Wenschuh | Holger | JPT Peptide Technology, GmbH: Employment (full- or part-time) |
| 68 | Weyburne | Emily | Unanswered |
| 85 | Wickham | Thomas | Gentibio: Employment (full- or part-time) |
| 246 | Widger | Jenifer | Celldex Therapeutics: Employment (full- or part-time) |
| 68 | Wiestner | Adrian | Pharmacyclics LLC: Research Grants, Salary Support, in-kind support; Acerta Pharma: Research Grants, Salary Support, in-kind support; Merck: Research Grants, Salary Support, in-kind support; Nurix: Research Grants, Salary Support, in-kind support; Veraste |
| 73 | Wiethe | Carsen | BioLegend: Employment (full- or part-time); PerkinElmer: Employment (full- or part-time) |
| 63 | Wilkens | Margaret | Agenus Inc. : Employment (full- or part-time) |
| 63 | Wilky | Breelyn | Agenus Inc. : Research Grants, Salary Support, in-kind support |
| 251 | Williams | Stephen | 10x Genomics: Employment (full- or part-time) |
| 159 | Wolf | Mary | Merck & Co.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Merck & Co.: Employment (full- or part-time) |
| 79 | Woodham | Andrew | Emulate: Employment (full- or part-time) |
| 250 | Wright | Adam | Unanswered |
| 237 | Wu | Meirong | gempharmatech: Employment (full- or part-time) |
| 250 | Wu | Sariena | GenomeFrontier: Employment (full- or part-time) |
| 187 | Wu | Hao | Ventus TX: Stock, stock options, or bond holdings in a for-profit corporation directly held or indirectly held within a self-directed pension, Consulting fees or other remuneration from for-profit entities, Ownership or partnership in a research foundatio |
| 155 | Xiang | Gao | gempharmatech ltd: Ownership or partnership |
| 243 | Xiao | Qiang | MilliporeSigma: Employment (full- or part-time) |
| 89 | Jun | gempharmatech: Employment (full- or part-time) | |
| 159 | Xu | Jiangsheng | ARV Technologies: Employment (full- or part-time) |
| 159 | Xu | Renhuan | ARV Technologies: Ownership or partnership |
| 155 | Xu | Shuxin | gemphamatech ltd: Employment (full- or part-time) |
| 250 | Xu | Wenxi | Standard BioTools: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Standard BioTools: Employment (full- or part-time) |
| 85 | Yam | Jennifer | GentiBio: Employment (full- or part-time) |
| 167 | Yang | Vicky | Cell Signaling Technology: Employment (full- or part-time) |
| 151 | Yang | Zhiyong | Genentech: Employment (full- or part-time); Roche Group: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 250 | Yang | Xifeng | PerkinElmer: Employment (full- or part-time) |
| 250 | Yao | Huihui | Standard BioTools: Employment (full- or part-time); Standard BioTools: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 222 | Yarmarkovich | Mark | Hula Therapeutics Inc: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 218 | Yeo | Gene | Locanabio: Positions of influence such as officer, board member, trustee, spokesperson; Eclipse BioInnovations: Positions of influence such as officer, board member, trustee, spokesperson |
| 51 | Yu | Julia | Advanced Cell Diagnostics, a Bio-Techne brand: Employment (full- or part-time); Advanced Cell Diagnostics, a Bio-Techne brand: Employment (full- or part-time) |
| 237 | Yu | Weiwei | gempharmatech: Employment (full- or part-time) |
| 249 | Yuan | Jessica | Akoya Biosciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan; Akoya Biosciences: Employment (full- or part-time) |
| 249 | Zabinyakov | Nick | Standard BioTools: Employment (full- or part-time); Standard BioTools (formerly Fluidigm): Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 85 | Zarin | Payam | GentiBio Inc. : Employment (full- or part-time) |
| 167 | Zee | Barry | Cell Signaling Technology: Employment (full- or part-time) |
| 165 | Zeidan | Ryan | Sling therapeutics : Research Grants, Salary Support, in-kind support |
| 157 | Zeng | Wei-ping | Therazwimm Corporation: Ownership or partnership |
| 89 | Zent | Clive S. | Acerta/AstraZeneca: Research Grants, Salary Support, in-kind support; GenMab: Research Grants, Salary Support, in-kind support; TG Therapeutics: Research Grants, Salary Support, in-kind support |
| 146 | Zent | Clive | AstraZeneca: Research Grants, Salary Support, in-kind support; TG Therapeutics: Research Grants, Salary Support, in-kind support; Genmab: Research Grants, Salary Support, in-kind support |
| 251 | Zerweck | Jonny | JPT Peptide Technology, GmbH: Employment (full- or part-time) |
| 155 | Zhang | Yuxi | Unanswered |
| 169 | Zhang | Mingkun | gempharmatech: Employment (full- or part-time) |
| 237 | Zhao | Jing | gempharmatech: Employment (full- or part-time) |
| 88 | Zheng | Yi | Akoya Bioscience: Employment (full- or part-time) |
| 249 | Zhou | Steve | Advanced Cell Diagnostics: Employment (full- or part-time) |
| 159 | Zhu | Huabin | ARV Technologies: Stock options or bond holdings in a for-profit corporation or self-directed pension plan |
| 250 | Zhu | Tony | LASE Innovation: Employment (full- or part-time) |
| 129 | Zoe Kincaid | Eleanor | Cytek Biosciences: Stock, stock options, or bond holdings in a for-profit corporation directly held or indirectly held within a self-directed pension plan, Employment (full or part-time) in for-profit entities |
| 59 | Zucht | Hans-Dieter | Oncimmune Germany GmbH: Employment (full- or part-time) |
| 246 | Zurowski | David | Resilience: Employment (full- or part-time) |
